These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 35562264)

  • 21. Comparison of non-radiomics imaging features and radiomics models based on contrast-enhanced ultrasound and Gd-EOB-DTPA-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma within 5 cm.
    Zheng R; Zhang X; Liu B; Zhang Y; Shen H; Xie X; Li S; Huang G
    Eur Radiol; 2023 Sep; 33(9):6462-6472. PubMed ID: 37338553
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delta-radiomics models based on multi-phase contrast-enhanced magnetic resonance imaging can preoperatively predict glypican-3-positive hepatocellular carcinoma.
    Han Z; Dai H; Chen X; Gao L; Chen X; Yan C; Ye R; Li Y
    Front Physiol; 2023; 14():1138239. PubMed ID: 37601639
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiomics nomogram for the prediction of microvascular invasion of HCC and patients' benefit from postoperative adjuvant TACE: a multi-center study.
    Zhang K; Zhang L; Li WC; Xie SS; Cui YZ; Lin LY; Shen ZW; Zhang HM; Xia S; Ye ZX; He K; Shen W
    Eur Radiol; 2023 Dec; 33(12):8936-8947. PubMed ID: 37368104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
    Zhang Y; He D; Liu J; Wei YG; Shi LL
    World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomic analysis of Gd-EOB-DTPA-enhanced MRI predicts Ki-67 expression in hepatocellular carcinoma.
    Fan Y; Yu Y; Wang X; Hu M; Hu C
    BMC Med Imaging; 2021 Jun; 21(1):100. PubMed ID: 34130644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
    Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
    Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting microvascular invasion in hepatocellular carcinoma: A dual-institution study on gadoxetate disodium-enhanced MRI.
    Jiang H; Wei J; Fu F; Wei H; Qin Y; Duan T; Chen W; Xie K; Lee JM; Bashir MR; Wang M; Song B; Tian J
    Liver Int; 2022 May; 42(5):1158-1172. PubMed ID: 35243749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of vessels encapsulating tumor clusters pattern and prognosis of hepatocellular carcinoma based on preoperative gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid magnetic resonance imaging.
    Wang M; Cao L; Wang Y; Huang H; Cao S; Tian X; Lei J
    J Gastrointest Surg; 2024 Apr; 28(4):442-450. PubMed ID: 38583894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Nomogram of Magnetic Resonance Imaging for Preoperative Assessment of Microvascular Invasion and Prognosis of Hepatocellular Carcinoma.
    Wang L; Zhang Y; Li J; Guo S; Ren J; Li Z; Zhuang X; Xue J; Lei J
    Dig Dis Sci; 2023 Dec; 68(12):4521-4535. PubMed ID: 37794295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J
    Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Magnetic resonance imaging and diffusion-weighted imaging-based histogram analyses in predicting glypican 3-positive hepatocellular carcinoma.
    Zhao J; Gao S; Sun W; Grimm R; Fu C; Han J; Sheng R; Zeng M
    Eur J Radiol; 2021 Jun; 139():109732. PubMed ID: 33905978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients.
    Zheng BH; Liu LZ; Zhang ZZ; Shi JY; Dong LQ; Tian LY; Ding ZB; Ji Y; Rao SX; Zhou J; Fan J; Wang XY; Gao Q
    BMC Cancer; 2018 Nov; 18(1):1148. PubMed ID: 30463529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC.
    Sheng L; Wei H; Yang T; Yang J; Zhang L; Zhu X; Jiang H; Song B
    Eur J Radiol; 2024 Jan; 170():111200. PubMed ID: 37995512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    Chen Y; Xia Y; Tolat PP; Long L; Jiang Z; Huang Z; Tang Q
    AJR Am J Roentgenol; 2021 Jun; 216(6):1510-1520. PubMed ID: 33826360
    [No Abstract]   [Full Text] [Related]  

  • 35. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
    Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
    J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram Estimating Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma From Preoperative Gadoxetate Disodium-Enhanced MRI.
    Chen FM; Du M; Qi X; Bian L; Wu D; Zhang SL; Wang J; Zhou Y; Zhu X
    J Magn Reson Imaging; 2023 Jun; 57(6):1893-1905. PubMed ID: 36259347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
    Li N; Dong T; Wang P; Li Q; Nie F
    Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma.
    Yan Y; Lin XS; Ming WZ; Chuan ZQ; Hui G; Juan SY; Shuang W; Yang Fan LV; Dong Z
    Acad Radiol; 2024 Mar; 31(3):859-869. PubMed ID: 37689559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative prediction of microvascular invasion in hepatocellular cancer: a radiomics model using Gd-EOB-DTPA-enhanced MRI.
    Feng ST; Jia Y; Liao B; Huang B; Zhou Q; Li X; Wei K; Chen L; Li B; Wang W; Chen S; He X; Wang H; Peng S; Chen ZB; Tang M; Chen Z; Hou Y; Peng Z; Kuang M
    Eur Radiol; 2019 Sep; 29(9):4648-4659. PubMed ID: 30689032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.